Transglutaminase 6 antibodies in the diagnosis of gluten ataxia
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: The previous finding of an immunologic response primarily directed against transglutaminase (TG)6 in patients with gluten ataxia (GA) led us to investigate the role of TG6 antibodies in diagnosing GA. METHODS: This was a prospective cohort study. We recruited patients from the ataxia, gluten/neurology, celiac disease (CD), and movement disorder clinics based at Royal Hallamshire Hospital (Sheffield, UK) and the CD clinic, Tampere University Hospital (Tampere, Finland). The groups included patients with idiopathic sporadic ataxia, GA, and CD, and neurology and healthy controls. All were tested for TG6 antibodies. Duodenal biopsies were performed in patients with positive serology. In addition, biopsies from 15 consecutive patients with idiopathic sporadic ataxia and negative serology for gluten-related disorders were analyzed for immunoglobulin A deposits against TG. RESULTS: The prevalence of TG6 antibodies was 21 of 65 (32%) in idiopathic sporadic ataxia, 35 of 48 (73%) in GA, 16 of 50 (32%) in CD, 4 of 82 (5%) in neurology controls, and 2 of 57 (4%) in healthy controls. Forty-two percent of patients with GA had enteropathy as did 51% of patients with ataxia and TG6 antibodies. Five of 15 consecutive patients with idiopathic sporadic ataxia had immunoglobulin A deposits against TG2, 4 of which subsequently tested positive for TG6 antibodies. After 1 year of gluten-free diet, TG6 antibody titers were significantly reduced or undetectable. CONCLUSIONS: Antibodies against TG6 are gluten-dependent and appear to be a sensitive and specific marker of GA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gluten sensitivity: from gut to brain
Hadjivassiliou, M., Sanders, D. S., Grünewald, R. A., Woodroofe, N., Boscolo, S., & Aeschlimann, D. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70290-x · Cited by 404
Self-citation
Cited by
Lebwohl, B., Sanders, D. S., & Green, P. H. R. (2018) · The Lancet · doi:10.1016/s0140-6736(17)31796-8 · Cited by 1,065
Self-citationSankowski, R., Mader, S., & Valdés-Ferrer, S. I. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00028 · Cited by 351
Balint, B., Vincent, A., Meinck, H.-M., Irani, S. R., & Bhatia, K. P. (2018) · Brain · doi:10.1093/brain/awx189 · Cited by 203
“TG6 antibodies have been described in patients with gluten sensitivity, but their sensitivity, specificity and diagnostic utility as well as their pathophysiological role remain very controversial (Hadjivassiliou et al., 2008; Boscolo et al., 2010; Lindfors et al., 2011; Hadjivassiliou et al., 2013; McKeon et al., 201…”
BackgroundConsensus Paper: Neuroimmune Mechanisms of Cerebellar Ataxias
Mitoma, H., Adhikari, K., Aeschlimann, D., Chattopadhyay, P., Hadjivassiliou, M., Hampe, C. S., Honnorat, J., Joubert, B., Kakei, S., Lee, J., et al. (2016) · The Cerebellum · doi:10.1007/s12311-015-0664-x · Cited by 183
“The development of newer serological markers, more specific to neurological manifestations (anti-TG6 antibodies) may assist in improving the diagnosis but are not as yet readily available [86, 87].”
BackgroundSelf-citation
Metadata
- Authors
- Hadjivassiliou, M., Aeschlimann, P., Sanders, D. S., Mäki, M., Kaukinen, K., Grünewald, R. A., Bandmann, O., Woodroofe, N., Haddock, G., & Aeschlimann, D. P.
- Venue
- Neurology
- Published
- 2013-05-07
- Volume
- 80
- Issue
- 19
- Pages
- 1740-1745
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2084359554
- Cited by
- 158
- References
- 1
- FWCI
- 12.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. https://app.cochat.ai/papers/10.1212/wnl.0b013e3182919070
- The paper
- Hadjivassiliou, M., Aeschlimann, P., Sanders, D. S., Mäki, M., Kaukinen, K., Grünewald, R. A., Bandmann, O., Woodroofe, N., Haddock, G., & Aeschlimann, D. P. (2013). Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology. https://doi.org/10.1212/wnl.0b013e3182919070
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.